Enzalutamide Xtandi 40 mg USA

Enzalutamide Xtandi 40 mg USA

Enzalutamide Capsules 40 mg

Enzalutamide 40 mg is an oral anti-androgen medication used in the treatment of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). It belongs to a class of drugs known as androgen receptor inhibitors, which work by blocking the effect of male hormones (androgens), such as testosterone, that fuel the growth of prostate cancer cells.

Enzalutamide is particularly effective because it works on multiple levels — it prevents androgens from binding to their receptors, blocks movement of the androgen-receptor complex into the cell nucleus, and inhibits interaction with DNA. This broad mechanism ultimately slows or stops the growth of hormone-driven prostate tumors.

Brand Name: Xtandi
Generic Name: Enzalutamide
Dosage Form: Oral capsule
Strength: 40 mg

Indications

Enzalutamide 40 mg is indicated for the treatment of:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

• Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

It is often used in combination with surgical or medical castration (use of luteinizing hormone-releasing hormone [LHRH] analogs or orchiectomy).